Results 181 to 190 of about 15,263 (240)

A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics. [PDF]

open access: yesMol Genet Metab Rep
Zhang L   +11 more
europepmc   +1 more source

An injectable hydrogel containing <i>N</i>-acetylglycine for the treatment of Gaucher disease. [PDF]

open access: yesRSC Adv
Pradhan L   +9 more
europepmc   +1 more source

Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies. [PDF]

open access: yesJ Clin Med
Zimran A   +11 more
europepmc   +1 more source

MyGauch<sup>TM</sup>: a patient-centered digital health app for Gaucher disease. [PDF]

open access: yesMhealth
Istaiti M   +7 more
europepmc   +1 more source

In silico biophysics and rheology of blood and red blood cells in Gaucher Disease. [PDF]

open access: yesPLoS Comput Biol
Chai Z   +6 more
europepmc   +1 more source

Chronic Myeloid Leukemia Transforming into Acute Lymphoblastic Leukemia in a Patient with Gaucher Disease: A Case Report and Literature Review. [PDF]

open access: yesCase Rep Oncol
Sayınalp Arslan B   +5 more
europepmc   +1 more source

The Role of Glycosphingolipids in Autoimmune Manifestations and Myeloma in Gaucher Disease

open access: yes
Pavlova E   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy